YETI Holdings
YETI
Halozyme Therapeutics
HALO
eBay
EBAY
4
Constellation Brands
STZ
5
Workday
WDAY
(Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 93.56%49.81M | -5.14%179.11M | 38.52%52.16M | -17.84%44.52M | -25.41%56.69M | 22.76%25.73M | 134.86%188.81M | -26.90%37.66M | 159.32%54.18M | 294.95%76.01M |
Net income from continuing operations | -10.88%15.06M | -12.41%54.34M | -21.81%10.53M | -34.45%10.42M | 9.97%16.49M | -4.41%16.9M | 104.35%62.04M | 295.25%13.47M | 20.34%15.9M | 70.97%14.99M |
Operating gains losses | 135.27%1.19M | 83.83%-701K | 285.67%3.06M | 335.49%3.2M | -333.90%-3.6M | -569.32%-3.36M | ---4.34M | ---1.65M | ---1.36M | ---829K |
Depreciation and amortization | 54.75%1.11M | 39.19%3.18M | 36.91%868K | 44.56%837K | 43.07%754K | 32.35%716K | 42.47%2.28M | 42.15%634K | 42.96%579K | 36.53%527K |
Deferred tax | -99.62%11K | -379.20%-10.46M | -882.85%-20.81M | -4.15%4.83M | 21.83%2.65M | 313.59%2.88M | 156.61%3.75M | -1,766.93%-2.12M | 401.32%5.04M | 2,454.12%2.17M |
Other non cash items | ---- | ---- | ---- | ---- | --113K | ---190K | ---34K | ---92K | ---- | ---- |
Change In working capital | 78.82%-5.73M | 32.42%-11.78M | 483.26%23.99M | -338.56%-11.19M | -89.24%2.46M | 14.07%-27.03M | 70.71%-17.42M | -144.30%-6.26M | 85.77%-2.55M | 230.84%22.85M |
-Change in receivables | -15.99%-69.73M | 54.58%-9.87M | 89.37%41.71M | 209.28%9.92M | -103.15%-1.38M | 23.34%-60.12M | 81.78%-21.74M | 58.91%22.02M | 71.42%-9.08M | 222.99%43.74M |
-Change in prepaid assets | -115.71%-2.38M | 178.58%18.02M | 200.03%20.41M | -155.13%-3.68M | -79.62%-13.89M | 1,141.83%15.17M | -40,328.07%-22.93M | -1,130.82%-20.41M | 415.15%6.67M | -812.72%-7.73M |
-Change in payables and accrued expense | 277.44%67.13M | -176.49%-20.34M | -379.93%-38.55M | -31,477.78%-17.05M | 229.28%17.47M | -63.10%17.79M | -56.28%26.6M | -546.47%-8.03M | -100.44%-54K | -179.47%-13.51M |
-Change in other working capital | -663.36%-738K | -34.41%425K | 169.87%421K | -329.21%-382K | -29.17%255K | -40.72%131K | 160.00%648K | 20.00%156K | -156.33%-89K | 5,900.00%360K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 93.56%49.81M | -5.14%179.11M | 38.52%52.16M | -17.84%44.52M | -25.41%56.69M | 22.76%25.73M | 134.86%188.81M | -26.90%37.66M | 159.32%54.18M | 294.95%76.01M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -589.09%-94.61M | 197.64%195.79M | 180.28%74.99M | 123.89%15.36M | 246.12%86.1M | 19.95%19.34M | -357.13%-200.53M | -7,863.68%-93.41M | -3,328.30%-64.32M | -4,580.14%-58.92M |
Net PPE purchase and sale | -234.47%-2.84M | -48.33%-5.41M | -178.27%-1.9M | -88.25%-1.79M | -14.10%-866K | 32.05%-850K | -12.43%-3.64M | 5.55%-681K | 23.15%-953K | -54.90%-759K |
Net business purchase and sale | ---9.34M | ---5.3M | --0 | --0 | ---5.3M | --0 | --0 | --0 | --0 | ---- |
Net investment purchase and sale | -508.18%-82.43M | 204.89%206.5M | 182.91%76.89M | 127.08%17.16M | 258.63%92.27M | 16.20%20.19M | -384.63%-196.88M | -20,416.15%-92.73M | -9,862.58%-63.36M | -7,463.59%-58.16M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -589.09%-94.61M | 197.64%195.79M | 180.28%74.99M | 123.89%15.36M | 246.12%86.1M | 19.95%19.34M | -357.13%-200.53M | -7,863.68%-93.41M | -3,328.30%-64.32M | -4,580.14%-58.92M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 88.00%-3.29M | -2,698.77%-309.88M | -1,020.94%-56.33M | -2,582.18%-63.35M | -8,752.04%-162.79M | -1,384.89%-27.41M | -40.79%-11.07M | -80.37%-5.03M | -92.35%-2.36M | 11.50%-1.84M |
Net common stock issuance | --0 | ---300.28M | ---55.1M | ---61.45M | ---159.96M | ---23.76M | --0 | --0 | --0 | --0 |
Proceeds from stock option exercised by employees | -77.52%295K | -60.85%2.4M | -76.84%387K | -55.73%317K | -78.39%383K | -33.37%1.31M | 45.04%6.13M | 24.15%1.67M | -34.55%716K | 211.42%1.77M |
Net other financing activities | 27.75%-3.58M | 30.23%-12M | 75.93%-1.61M | 27.97%-2.22M | 11.02%-3.21M | -29.99%-4.96M | -42.28%-17.2M | -62.05%-6.7M | -32.56%-3.08M | -36.42%-3.61M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 88.00%-3.29M | -2,698.77%-309.88M | -1,020.94%-56.33M | -2,582.18%-63.35M | -8,752.04%-162.79M | -1,384.89%-27.41M | -40.79%-11.07M | -80.37%-5.03M | -92.35%-2.36M | 11.50%-1.84M |
Net cash flow | ||||||||||
Beginning cash position | 66.82%162.31M | -18.97%97.3M | -42.13%91.48M | -44.33%94.96M | -25.99%114.96M | -18.97%97.3M | 31.36%120.08M | 117.97%158.08M | 211.66%170.57M | 300.09%155.32M |
Current changes in cash | -372.23%-48.09M | 385.38%65.02M | 216.53%70.83M | 72.18%-3.48M | -231.14%-20M | -49.88%17.67M | -179.48%-22.78M | -227.80%-60.78M | -170.24%-12.5M | -4.14%15.25M |
Effect of exchange rate changes | 850.00%15K | 0.00%1K | 600.00%7K | ---4K | --0 | ---2K | --1K | --1K | --0 | --0 |
End cash Position | -0.63%114.24M | 66.82%162.31M | 66.82%162.31M | -42.13%91.48M | -44.33%94.96M | -25.99%114.96M | -18.97%97.3M | -18.97%97.3M | 117.97%158.08M | 211.66%170.57M |
Free cash flow | 88.75%46.97M | -6.19%173.7M | 35.94%50.27M | -19.74%42.72M | -25.81%55.83M | 26.24%24.88M | 140.00%185.17M | -27.20%36.98M | 170.83%53.23M | 301.22%75.25M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |